Bentham Science Logo

Track Your Manuscript:


Current Signal Transduction Therapy

Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 4 - Number 1



Leptin Signaling: A Key Pathway in Immune Responses

, 4(1): 22 - 30

Claudio Procaccini, Elaine V. Lourenço, Giuseppe Matarese and Antonio La Cava


DOI: 10.2174/157436209787048711


Sonic Hedgehog Pathway as a Target for Therapy in Angiogenesis-Related Diseases

, 4(1): 31 - 45

Chiara Porro, Raffaella Soleti, Tarek Benameur, Angela Bruna Maffione, Ramaroson Andriantsitohaina and Maria Carmen Martinez


DOI: 10.2174/157436209787048694







Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.

Advertisement

How to write and publish your papers in high impact journalsPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog